Takashi Tokunaga
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: November 18, 2019
EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma.
Journal: Cancer medicine
Published: October 07, 2019
Acute Promyelocytic Leukemia and HIV: Case Reports and a Review of the Literature.
Journal: Internal medicine (Tokyo, Japan)
Published: May 24, 2019
Combined Inhibition of ALK and HDAC Induces Synergistic Cytotoxicity in Neuroblastoma Cell Lines.
Journal: Anticancer research
Published: April 01, 2019
EBV-positive Reactive Hyperplasia Progressed into EBV-positive Diffuse Large B-cell Lymphoma of the Elderly over a 6-year Period.
Journal: Internal medicine (Tokyo, Japan)
Published: December 28, 2017
Synergistic Cytotoxicity of Bendamustine and the BTK Inhibitor in a Mantle Cell Lymphoma Cell Line.
Journal: Anticancer research
Published: December 06, 2015
De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: molecular mechanisms and correlation with rituximab sensitivity.
Journal: Cancer science
Published: August 29, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026